GENNQ (Genesis Healthcare) Short-Term Debt: $906 Mil (As of Dec. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GENNQ Genesis Healthcare Inc GENNQ
12 GF Score
Price $0.00
View Full Analysis

What is Genesis Healthcare Short-Term Debt?

Genesis Healthcare GENNQ -99.00% 12 Short-Term Debt is $906 Mil as of Dec. 2020. GuruFocus rates GENNQ with a GF Score™ of 12/100.

Genesis Healthcare's Short-Term Debt for the quarter that ended in Dec. 2020 was $906 Mil.

Genesis Healthcare's quarterly Short-Term Debt declined from Jun. 2020 ($19 Mil) to Sep. 2020 ($11 Mil) but then increased from Sep. 2020 ($11 Mil) to Dec. 2020 ($906 Mil).

Genesis Healthcare's annual Short-Term Debt increased from Dec. 2018 ($123 Mil) to Dec. 2019 ($162 Mil) and increased from Dec. 2019 ($162 Mil) to Dec. 2020 ($906 Mil).

Genesis Healthcare Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Genesis Healthcare Short-Term Debt Related Terms

Genesis Healthcare Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Genesis Healthcare's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genesis Healthcare Short-Term Debt Chart

Genesis Healthcare Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.59 26.96 122.53 162.43 905.79

Genesis Healthcare Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 162.43 106.09 19.12 10.69 905.79
GENNQ
12GF Score
Genesis Healthcare Inc GENNQ
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $906 Mil mean?
Genesis Healthcare (GENNQ) has a Short-Term Debt of $906 Mil as of Dec. 2020.
Is Genesis Healthcare's Short-Term Debt too high?
Genesis Healthcare's current Short-Term Debt is $906 Mil. Overall, Genesis Healthcare has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Genesis Healthcare's Short-Term Debt compare to AIH and JYNT?
Genesis Healthcare's Short-Term Debt of $906 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Genesis Healthcare's current Short-Term Debt is $906 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genesis Healthcare stock overvalued right now?
Genesis Healthcare (GENNQ) has a current Short-Term Debt of $906 Mil. The current Short-Term Debt is $906 Mil. Genesis Healthcare's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Genesis Healthcare (GENNQ), the current Short-Term Debt is $906 Mil as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genesis Healthcare Business Description

Address 101 East State Street, Kennett Square, PA, USA, 19348
Genesis Healthcare Inc is a post-acute care provider in the United States. It focuses on the medical and physical issues facing elderly patients and is provided by the employees of skilled nursing facilities, assisted/senior living communities, integrated and third-party rehabilitation therapy business. The company has three operating segments. The inpatient services segment include the operation of skilled nursing facilities and assisted/senior living facilities; rehabilitation therapy segment services include integrated and third-party rehabilitation and respiratory therapy services; and all other services. The majority of its revenue is generated from its skilled nursing facilities of the inpatient services segment.
12GF Score

Get the complete analysis for GENNQ

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price